Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Lung Cancer

  Free Subscription


Articles published in Nat Med

Retrieve available abstracts of 17 articles:
HTML format
Text format



Single Articles


    November 2018
  1. SHAH KN, Bhatt R, Rotow J, Rohrberg J, et al
    Aurora kinase A drives the evolution of resistance to third-generation EGFR inhibitors in lung cancer.
    Nat Med. 2018 Nov 26. pii: 10.1038/s41591-018-0264.
    PubMed     Text format     Abstract available


  2. FORMENTI SC, Rudqvist NP, Golden E, Cooper B, et al
    Radiotherapy induces responses of lung cancer to CTLA-4 blockade.
    Nat Med. 2018 Nov 5. pii: 10.1038/s41591-018-0232.
    PubMed     Text format     Abstract available


    September 2018
  3. COUDRAY N, Ocampo PS, Sakellaropoulos T, Narula N, et al
    Classification and mutation prediction from non-small cell lung cancer histopathology images using deep learning.
    Nat Med. 2018 Sep 17. pii: 10.1038/s41591-018-0177.
    PubMed     Text format     Abstract available


    August 2018
  4. DERIBE YL, Sun Y, Terranova C, Khan F, et al
    Author Correction: Mutations in the SWI/SNF complex induce a targetable dependence on oxidative phosphorylation in lung cancer.
    Nat Med. 2018 Aug 13. pii: 10.1038/s41591-018-0173.
    PubMed     Text format     Abstract available


  5. HOYLES L, Fernandez-Real JM, Federici M, Serino M, et al
    Publisher Correction: Global characterization of T cells in non-small-cell lung cancer by single-cell sequencing.
    Nat Med. 2018 Aug 9. pii: 10.1038/s41591-018-0169.
    PubMed     Text format     Abstract available


  6. GUO X, Zhang Y, Zheng L, Zheng C, et al
    Publisher Correction: Global characterization of T cells in non-small-cell lung cancer by single-cell sequencing.
    Nat Med. 2018 Aug 9. pii: 10.1038/s41591-018-0167.
    PubMed     Text format     Abstract available


  7. GANDARA DR, Paul SM, Kowanetz M, Schleifman E, et al
    Blood-based tumor mutational burden as a predictor of clinical benefit in non-small-cell lung cancer patients treated with atezolizumab.
    Nat Med. 2018 Aug 6. pii: 10.1038/s41591-018-0134.
    PubMed     Text format     Abstract available


    June 2018
  8. GUO X, Zhang Y, Zheng L, Zheng C, et al
    Global characterization of T cells in non-small-cell lung cancer by single-cell sequencing.
    Nat Med. 2018 Jun 25. pii: 10.1038/s41591-018-0045.
    PubMed     Text format     Abstract available


  9. THOMMEN DS, Koelzer VH, Herzig P, Roller A, et al
    A transcriptionally and functionally distinct PD-1(+) CD8(+) T cell pool with predictive potential in non-small-cell lung cancer treated with PD-1 blockade.
    Nat Med. 2018 Jun 11. pii: 10.1038/s41591-018-0057.
    PubMed     Text format     Abstract available


  10. LISSANU DERIBE Y, Sun Y, Terranova C, Khan F, et al
    Mutations in the SWI/SNF complex induce a targetable dependence on oxidative phosphorylation in lung cancer.
    Nat Med. 2018 Jun 8. pii: 10.1038/s41591-018-0019.
    PubMed     Text format     Abstract available


    May 2018
  11. MAINARDI S, Mulero-Sanchez A, Prahallad A, Germano G, et al
    SHP2 is required for growth of KRAS-mutant non-small-cell lung cancer in vivo.
    Nat Med. 2018 May 28. pii: 10.1038/s41591-018-0023.
    PubMed     Text format     Abstract available


    April 2018
  12. ROBICHAUX JP, Elamin YY, Tan Z, Carter BW, et al
    Mechanisms and clinical activity of an EGFR and HER2 exon 20-selective kinase inhibitor in non-small cell lung cancer.
    Nat Med. 2018 Apr 23. pii: 10.1038/s41591-018-0007.
    PubMed     Text format     Abstract available


    March 2018
  13. DARDAEI L, Wang HQ, Singh M, Fordjour P, et al
    SHP2 inhibition restores sensitivity in ALK-rearranged non-small-cell lung cancer resistant to ALK inhibitors.
    Nat Med. 2018 Mar 5. pii: nm.4497. doi: 10.1038/nm.4497.
    PubMed     Text format     Abstract available


    October 2017
  14. ROMERO R, Sayin VI, Davidson SM, Bauer MR, et al
    Keap1 loss promotes Kras-driven lung cancer and results in dependence on glutaminolysis.
    Nat Med. 2017 Oct 2. doi: 10.1038/nm.4407.
    PubMed     Text format     Abstract available


    August 2017
  15. XUE Y, Martelotto L, Baslan T, Vides A, et al
    An approach to suppress the evolution of resistance in BRAFV600E-mutant cancer.
    Nat Med. 2017;23:929-937.
    PubMed     Text format     Abstract available


    July 2017
  16. MAYORCA-GUILIANI AE, Madsen CD, Cox TR, Horton ER, et al
    ISDoT: in situ decellularization of tissues for high-resolution imaging and proteomic analysis of native extracellular matrix.
    Nat Med. 2017;23:890-898.
    PubMed     Text format     Abstract available


    June 2017
  17. RICKMAN DS, Beltran H, Demichelis F, Rubin MA, et al
    Biology and evolution of poorly differentiated neuroendocrine tumors.
    Nat Med. 2017;23:1-10.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: